{"id":2617,"date":"2017-02-14T03:00:59","date_gmt":"2017-02-14T08:00:59","guid":{"rendered":"https:\/\/issels.com\/blog\/?p=2617"},"modified":"2017-01-21T16:22:25","modified_gmt":"2017-01-21T21:22:25","slug":"the-presence-of-a-molecular-marker-may-predict-breast-cancer-for-early-treatment","status":"publish","type":"post","link":"https:\/\/issels.com\/blog\/2017\/02\/14\/the-presence-of-a-molecular-marker-may-predict-breast-cancer-for-early-treatment\/","title":{"rendered":"The Presence of a Molecular Marker May Predict Breast Cancer for Early Treatment"},"content":{"rendered":"<figure id=\"attachment_2253\" aria-describedby=\"caption-attachment-2253\" style=\"width: 200px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2253\" src=\"https:\/\/issels.com\/blog\/wp-content\/uploads\/2015\/12\/Cells-2.jpg\" width=\"200\" height=\"142\" \/><figcaption id=\"caption-attachment-2253\" class=\"wp-caption-text\">The Molecular Mark<\/figcaption><\/figure>\n<p><a href=\"http:\/\/issels.com\">Breast cancer<\/a> is still the leading cause of death for women who suffer from cancer, but early detection can improve the chances of successful treatment. In 2016 a group of researchers identified a <a href=\"http:\/\/news.harvard.edu\/gazette\/story\/2016\/04\/new-weapon-against-breast-cancer\/\">molecular marker<\/a> that can indicate a woman&#8217;s risk for developing the disease.<\/p>\n<p><strong>Identifying a Common Thread<\/strong><\/p>\n<p>The study was conducted by a joint team from Harvard Stem Cell Institute (HSCI), Dana-Farber Cancer Institute (DFCI), and Brigham and Women&#8217;s Hospital (BWH). Researchers reviewed biopsies from 302 women who had been diagnosed with benign breast disease. Some of the biopsies dated back to 40 years ago.<\/p>\n<p>Out of this group, 69 women later developed cancer and 233 did not. It was discovered that women with a higher percentage of a particular marker were more likely to develop cancer.<\/p>\n<p>Ki67 is a molecular marker found in the lining of the mammary ducts and milk-producing lobules that identifies proliferating cells. These tissues are the site where most <a href=\"https:\/\/issels.com\/blog\/2015\/10\/27\/men-can-get-breast-cancer-too\/\">breast cancers<\/a> develop.<\/p>\n<p><strong>The Present and Future of Ki67 Testing<\/strong><\/p>\n<p>While Ki67 testing is already being used to determine courses of treatment, this discovery will allow doctors to test precancerous tissue for use as a predictive tool. The method could help avoid some of the drawbacks of <a href=\"https:\/\/issels.com\/blog\/2014\/08\/11\/mammograms-and-breast-cancer-the-problem-with-dense-tissue\/\">mammograms<\/a>, which are currently the best option for early detection.<\/p>\n<p><strong>Immunotherapy for Cancer: A Personalized Method of Treatment<\/strong><\/p>\n<p><a href=\"https:\/\/issels.com\/blog\/2015\/05\/11\/precision-cancer-treatments-use-genomics-for-tumor-targeting\/\">Genomic testing<\/a> is just one of the specialized tools we use to create our individually tailored therapies targeted to meet your personal needs. <a href=\"http:\/\/66.135.32.155\/issels\/Questionnaire\/request-issels-info.aspx\">Contact us<\/a> to learn why Issels\u00ae is the leader in non-toxic and effective immunotherapy for cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Breast cancer is still the leading cause of death for women who suffer from cancer, but early detection can improve the chances of successful treatment. In 2016 a group of researchers identified a molecular marker that can indicate a woman&#8217;s risk for developing the disease. Identifying a Common Thread The study was conducted by a &hellip; <a href=\"https:\/\/issels.com\/blog\/2017\/02\/14\/the-presence-of-a-molecular-marker-may-predict-breast-cancer-for-early-treatment\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">The Presence of a Molecular Marker May Predict Breast Cancer for Early Treatment<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202,473,203,216],"tags":[481,557,259],"class_list":["post-2617","post","type-post","status-publish","format-standard","hentry","category-alternative-cancer-treatment","category-breast-cancer","category-cancer-research","category-immunotherapy","tag-breast-cancer-treatment","tag-detecting-cancer","tag-fighting-cancer"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/comments?post=2617"}],"version-history":[{"count":1,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2617\/revisions"}],"predecessor-version":[{"id":2618,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/2617\/revisions\/2618"}],"wp:attachment":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/media?parent=2617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/categories?post=2617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/tags?post=2617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}